G. B.
- Country
- The Netherlands
- Department
- Medische Oncologie
Research Overview
- Phase III Multicenter Randomized Trial of Dose-Reduced Chemotherapy with Fluorouracil, Folinic Acid, Capecitabine, and Oxaliplatin in Metastatic Colorectal Cancer
- Phase 2 Randomized Study of Liposomal Irinotecan, Carboplatin, and Oxaliplatin in First-Line Treatment of Metastatic or Locally Advanced Esophagogastric Cancer
Data & Insights
Has run more than one trial at 25 of 56 partner sites.
Specializations
Gastrointestinal Oncology
The investigator specializes in treating advanced esophagogastric cancer, with particular focus on innovative therapeutic approaches for patients with metastatic and locally advanced disease states.
- Advanced Esophageal Cancer
- Gastric Cancer Management
- Metastatic Disease Treatment
Their research explores comprehensive treatment strategies for previously untreated patients with gastrointestinal malignancies.
Novel Therapeutic Approaches
The investigator's work centers on evaluating liposomal chemotherapy formulations and various platinum-based treatment combinations in gastrointestinal cancers.
- Liposomal Drug Delivery
- Platinum-Based Therapies
- Combination Treatment Strategies
Their research includes assessment of treatment efficacy and monitoring of specific side effects such as neurotoxicity.
Clinical Outcomes Research
The investigator focuses on evaluating progression-free survival and treatment-related outcomes in gastrointestinal cancer patients.
- Survival Analysis
- Treatment Response Assessment
- Side Effect Management
Their work encompasses the study of first-line treatment options for advanced gastrointestinal cancers.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.